Eliminating malaria - All of them

The Lancet

Volumn 376, Issue 9756, 2010, Pages 1883-1885

  Baird, J Kevin ^a,b  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRIMAQUINE;

DRUG EFFICACY; DRUG SAFETY; GAMETOCYTE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; MALARIA CONTROL; MALARIA FALCIPARUM; NONHUMAN; NOTE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SCHIZONT; TROPHOZOITE;

EID: 78649881484     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)61494-8     Document Type: Note

References (8)

1. LT Coggeshall The treatment of malaria Am J Trop Med Hyg 1 1952 124 131
2. WE Collins, GM Jeffery Primaquine resistance in Plasmodium vivax Am J Trop Med Hyg 55 1996 243 249
3. TN Wells, EM Poll When is enough enough? The need for a robust pipeline of high quality antimalarials Discov Med 9 2010 389 398
4. DL Doolan, C Dobaño, JK Baird Acquired immunity to malaria Clin Microbiol Rev 22 2009 13 36
5. E Beutler G6PD deficiency Blood 84 1994 3613 3636
6. JK Baird, KH Rieckmann 2003. Can primaquine therapy for vivax malaria be improved? Trends Parasitol 19 2003 115 120
7. O Branch, WM Casapia, DV Gamboa Clustered local transmission and asymptomatic Plasmodium falciparum and Plasmodium vivax malaria infections in a recently emerged, hypoendemic Peruvian Amazon community Malar J 4 2005 27
8. B Greenwood The use of anti-malarial drugs to prevent malaria in the population of malaria-endemic areas Am J Trop Med Hyg 70 2004 1 7